JAK2 and EPOR rearrangements, though not as common as the previously mentioned mutations in Ph-like ALL, are correlated with the poorest prognosis among all the subgroups, with a 23.5% 5-year EFS [41]. This evidence concerns the gene JAK2 and acute lymphoblastic leukemia.